The North America Nasal Spray Packaging market gathered revenue around USD 121 million units by the end of 2030 and is estimated to expand at a modest CAGR of 5.4% during the prediction period 2022 to 2030. However, certain materials such as metals in pump bottles and pressurized canisters are subject to reactivity in raw state of nasal spray formulations. In order to overcome this issue, manufacturers are using aluminum lined with epoxide, vinyl or phenolic resins to avoid reactivity in raw state of nasal spray formulations.
Tin is gaining popularity for being resistant to chemical attacks. However, it is one of the most expensive metals compared to aluminum, iron, and lead.
Report Scope of the Nasal Spray Packaging Market
Report Coverage |
Details |
Market Size |
US$ 121 million by 2030 |
Growth Rate |
CAGR of 5.4% from 2022 to 2030 |
Largest Market |
North America |
Base Year |
2021 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Container Type,Container Type,Dosage Form and Region, |
Companies Mentioned |
Berry North America Inc., Gerresheimer AG, AptarGroup, Inc., West Pharmaceutical Service Inc., Amcor PLC, Nolato AB, Bormioli Pharma United States Inc., Coster Tecnologie Speciali S.p.A, SGD S.A., and Comar LLC |
Adherence to CRSF Regulatory Requirements Enables Manufacturers to Bolster Credibility Credentials
Child-resistant and senior-friendly packaging solutions are of high demand in the North America nasal spray packaging market. Aptar Pharma - a specialist in product delivery systems and consumer packaging solutions is capitalizing on this opportunity to introduce its child-resistant and senior-friendly closure for nasal sprays. Manufacturers in the North America nasal spray packaging market are increasing their R&D capabilities to develop simple and intuitive nasal spray systems, whilst maintaining safety to gain a competitive edge over other market players.
Packaging companies in the U.S. nasal spray packaging market are adhering to regulatory requirements of CRSF (Child Resistant & Senior Friendly) packaging solutions for multi-dose dispensers. They are making use of well-established CRSF technologies that ensure safety during use and prevent accidental access.
Innovative Containers Compatible with Next Gen Saline, Seawater Nasal Sprays
Manufacturers in the North America nasal spray packaging market are boosting their output capacities in spray bottles with nebulizer and pump systems to establish steady income streams. Since saline nasal spray formulations are anticipated to dominate the highest revenue share among all drug types in the market, manufacturers are increasing their production capabilities in carbonated saline-based medical products.
Companies in the North America nasal spray packaging market are entering into partnerships to develop materials that support next gen saline and seawater nasal sprays. They are developing packaging solutions that are compatible with drug-free nasal rinses compounded with clinically proven ingredients of saline and carbon dioxide (CO2).
Turnkey Industrialized Packaging Formats Gain Prominence in Allergic Rhinitis Nasal Sprays
The high prevalence of seasonal and perennial allergic rhinitis in adults and children has triggered the demand for robust nasal spray formulations and packaging in the U.S. and Canada. The growing demand for a fixed-dose combination nasal spray is translating into revenue opportunities for companies in the North America nasal spray packaging market. Serious symptoms of allergic rhinitis such as runny nose, sneezing, watery eyes, and nasal itching have fueled the demand for nasal spray products.
Allergic rhinitis dramatically affects a person’s quality of life and leads to functional impairments. Hence, manufacturers in the North America nasal spray packaging market are taking advantage of this opportunity to boost their production capabilities for product containers and bottles. They are increasing focus in fully industrialized formats that are configured for existing filling and packaging lines.
Needle-free Vaccination and Systemic Delivery of Drugs Driving Nasal Spray Packaging Market in North America
Manufactures Facing Challenges to Meet Standards of Regulatory Requirements
North America Nasal Spray Packaging Market: Key Findings
In terms of volume, pump bottles are estimated to account for higher market share driven by economical price and wide drug usage. The segment is expected to capture around 4/5th of the market share by 2025.
Based on drug type, saline nasal spray is projected to account for nearly 35% of the market share by 2030 due to its increasing use in multi-dose types of packaging formats. On the other hand, the steroid nasal spray segment is anticipated to expand two-fold in North America.
In terms of dosage form, the multi-dose segment is anticipated to create highest incremental opportunity of US$ 25 Mn during the forecast period
The U.S. is expected to account for around 85% share of the market in North America market by 2025, and this market in the country is projected to witness substantial growth during the forecast period
Some of the prominent players in the Nasal Spray Packaging Market include:
Segments Covered in the Report
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at North America, regional, and country level for the period of 2017 to 2030 and covers subsequent region in its scope:
North America Nasal Spray Packaging Market Segmentation
North America Nasal Spray Packaging Market by Container Type
North America Nasal Spray Packaging Market by Drug Type
North America Nasal Spray Packaging Market by Dosage Form
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Nasal Spray Packaging Market Study:
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. TMR Analysis and Recommendations
1.4. Opportunity Analysis
2. Market Viewpoint
2.1. Market Definition
2.2. Market Taxonomy
3. Nasal Spray Packaging Market Overview
3.1. Introduction
3.2. North America Nasal Spray Packaging Market Overview
3.3. Macro-economic Factors – Correlation Analysis
3.4. Forecast Factors – Relevance & Impact
3.5. Nasal Spray Packaging Market Value Chain Analysis
3.5.1. Exhaustive List of Active Participants
3.5.1.1. Raw-material Suppliers
3.5.1.2. Manufacturers
3.5.1.3. End Users
3.5.2. Profitability Margins
4. Impact of COVID-19
4.1. Current Statistics and Probable Future Impact
4.2. Impact of COVID-19 on Nasal Spray Packaging Market
5. Nasal Spray Packaging Market Analysis
5.1. Pricing Analysis
5.1.1. Pricing Assumption
5.1.2. Price Projections By Country
5.2. Market Size (US$ Mn) and Forecast
5.2.1. Market Size and Y-o-Y Growth
5.2.2. Absolute $ Opportunity
6. Nasal Spray Packaging Market Dynamics
6.1. Drivers
6.2. Restraints
6.3. Opportunity Analysis
6.4. Trends
7. North America Nasal Spray Packaging Market Analysis and Forecast, By Container Type
7.1. Introduction
7.1.1. Market share and Basis Points (BPS) Analysis, By Container Type
7.1.2. Y-o-Y Growth Projections, By Container Type
7.2. Historical Market Value(US$ Mn) and Volume (Units), 2015-2019, By Container Type
7.2.1. Pump Bottles
7.2.2. Pressurized Canisters
7.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2020-2030, By Container Type
7.3.1. Pump Bottles
7.3.2. Pressurized Canisters
7.4. Market Attractiveness Analysis, By Container Type
8. North America Nasal Spray Packaging Market Analysis and Forecast, By Drug Type
8.1. Introduction
8.1.1. Market share and Basis Points (BPS) Analysis, By Drug Type
8.1.2. Y-o-Y Growth Projections, By Drug Type
8.2. Historical Market Value(US$ Mn) and Volume (Units), 2015-2019, By Drug Type
8.2.1. Saline Nasal Spray
8.2.2. Decongestion Nasal Spray
8.2.3. Steroid Nasal Spray
8.2.4. Antihistamine Nasal Spray
8.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2020-2030, By Drug Type
8.3.1. Saline Nasal Spray
8.3.2. Decongestion Nasal Spray
8.3.3. Steroid Nasal Spray
8.3.4. Antihistamine Nasal Spray
8.4. Market Attractiveness Analysis, By Drug Type
9. North America Nasal Spray Packaging Market Analysis and Forecast, By Dosage Form
9.1. Introduction
9.1.1. Market share and Basis Points (BPS) Analysis, By Dosage Form
9.1.2. Y-o-Y Growth Projections, By Dosage Form
9.2. Historical Market Value(US$ Mn) and Volume (Units), 2015-2019, By Dosage Form
9.2.1. Single-dose
9.2.2. Multi-dose
9.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2020-2030, By Dosage Form
9.3.1. Single-dose
9.3.2. Multi-dose
9.4. Market Attractiveness Analysis, By Dosage Form
10. North America Nasal Spray Packaging Market Analysis and Forecast, By Country
10.1. Introduction
10.1.1. Market share and Basis Points (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.2. Historical Market Value(US$ Mn) and Volume (Units), 2015-2019, By Country
10.2.1. U.S.
10.2.2. Canada
10.3. Market Size (US$ Mn) and Volume (Units) Forecast Analysis 2020-2030 By Country
10.3.1. U.S.
10.3.2. Canada
10.4. Market Attractiveness Analysis By Country
10.5. Prominent Trends
11. Competitive Landscape
11.1. Market Structure
11.2. Competition Dashboard
11.3. Company Market Share Analysis
11.4. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, SWOT analysis)
11.5. Competition Deep Dive
(North America Players)
11.5.1. Berry North America Inc.
11.5.1.1. Overview
11.5.1.2. Financials
11.5.1.3. Strategy
11.5.1.4. Recent Developments
11.5.1.5. SWOT Analysis
11.5.2. Gerresheimer AG
11.5.2.1. Overview
11.5.2.2. Financials
11.5.2.3. Strategy
11.5.2.4. Recent Developments
11.5.2.5. SWOT Analysis
11.5.3. AptarGroup, Inc.
11.5.3.1. Overview
11.5.3.2. Financials
11.5.3.3. Strategy
11.5.3.4. Recent Developments
11.5.3.5. SWOT Analysis
11.5.4. West Pharmaceutical Service Inc.
11.5.4.1. Overview
11.5.4.2. Financials
11.5.4.3. Strategy
11.5.4.4. Recent Developments
11.5.4.5. SWOT Analysis
11.5.5. Amcor PLC
11.5.5.1. Overview
11.5.5.2. Financials
11.5.5.3. Strategy
11.5.5.4. Recent Developments
11.5.5.5. SWOT Analysis
11.5.6. Nolato AB
11.5.6.1. Overview
11.5.6.2. Financials
11.5.6.3. Strategy
11.5.6.4. Recent Developments
11.5.6.5. SWOT Analysis
11.5.7. Bormioli Pharma
11.5.7.1. Overview
11.5.7.2. Financials
11.5.7.3. Strategy
11.5.7.4. Recent Developments
11.5.7.5. SWOT Analysis
11.5.8. Coster Tecnologie Speciali S.p.A
11.5.8.1. Overview
11.5.8.2. Financials
11.5.8.3. Strategy
11.5.8.4. Recent Developments
11.5.8.5. SWOT Analysis
11.5.9. SGD S.A.
11.5.9.1. Overview
11.5.9.2. Financials
11.5.9.3. Strategy
11.5.9.4. Recent Developments
11.5.9.5. SWOT Analysis
11.5.10. Comar LLC
11.5.10.1. Overview
11.5.10.2. Financials
11.5.10.3. Strategy
11.5.10.4. Recent Developments
11.5.10.5. SWOT Analysis
*The list of companies is indicative in nature and is subject to change during the course of research